As Moscow announced the beginning of post-registration trials of anti-COVID vaccine Sputnik V on 26 August, the US added a group of Russian research institutes, including the one testing the anti-coronavirus drug, to its sanctions list. International observers have discussed the US move unveiled amid the global effort to curb the pandemic.
According to a statement, released by the US Department of Commerce on Wednesday, the Bureau of Industry and Security (BIS) has amended the Export Administration Regulations (EAR) by adding sixty entities under the destinations of nine countries to its sanctions list. These entities have been determined “to be acting contrary to the national security or foreign policy interests of the US” and will be subjected to restrictions on the export, re-export, and transfer of goods to them.
Continue reading https://sptnkne.ws/D2S5